# FDA Inspection 1166059 - Peter Charles Klatsky, M.D., Inc. - March 23, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/peter-charles-klatsky-md-inc/fecc8f97-0946-4a0f-8f43-86c29162efc3/
Source feed: FDA_Inspections

> FDA Inspection 1166059 for Peter Charles Klatsky, M.D., Inc. on March 23, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166059
- Company Name: Peter Charles Klatsky, M.D., Inc.
- Inspection Date: 2022-03-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1284460 - 2025-09-23](https://www.globalkeysolutions.net/api/records/fda_inspections/peter-charles-klatsky-md-inc/f7e15600-aaf7-462e-955a-92930655e850/)
- [FDA Inspection 1166059 - 2022-03-23](https://www.globalkeysolutions.net/api/records/fda_inspections/peter-charles-klatsky-md-inc/0cfb5630-086e-42d6-a5f5-69bc088fec53/)

Company: https://www.globalkeysolutions.net/companies/peter-charles-klatsky-md-inc/3bfa23f3-5af0-4953-9709-d5c81f582d21

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d